205 related articles for article (PubMed ID: 20355236)
1. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.
Dagnelie PC; Leij-Halfwerk S
World J Gastroenterol; 2010 Apr; 16(13):1577-86. PubMed ID: 20355236
[TBL] [Abstract][Full Text] [Related]
2. Development and applications of in vivo clinical magnetic resonance spectroscopy.
Cox IJ
Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
[TBL] [Abstract][Full Text] [Related]
3. Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide.
Solga SF; Horska A; Clark JM; Diehl AM
Liver Int; 2005 Jun; 25(3):490-500. PubMed ID: 15910484
[TBL] [Abstract][Full Text] [Related]
4. In vivo magnetic resonance spectroscopy of liver tumors and metastases.
ter Voert EG; Heijmen L; van Laarhoven HW; Heerschap A
World J Gastroenterol; 2011 Dec; 17(47):5133-49. PubMed ID: 22215937
[TBL] [Abstract][Full Text] [Related]
5. Multiple NMR T2 relaxation values in human liver tissue.
Bernardino ME; Small W; Goldstein J; Sewell CW; Sones PJ; Gedgaudas-McClees K; Galambos JT; Wenger J; Casarella WJ
AJR Am J Roentgenol; 1983 Dec; 141(6):1203-8. PubMed ID: 6606317
[TBL] [Abstract][Full Text] [Related]
6. Applications of magnetic resonance spectroscopy to chronic liver disease.
Taylor-Robinson SD
Clin Med (Lond); 2001; 1(1):54-60. PubMed ID: 11358078
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of the liver evaluated by 31P MRS.
Meyerhoff DJ; Karczmar GS; Weiner MW
Invest Radiol; 1989 Dec; 24(12):980-4. PubMed ID: 2606636
[TBL] [Abstract][Full Text] [Related]
8. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.
Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD
Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050
[TBL] [Abstract][Full Text] [Related]
10. [(1)H magnetic resonance spectroscopy (MRS) of the liver and hepatic malignant tumors at 3.0 Tesla].
Fischbach F; Thormann M; Ricke J
Radiologe; 2004 Dec; 44(12):1192-6. PubMed ID: 15549225
[TBL] [Abstract][Full Text] [Related]
11. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review.
Fischbach F; Bruhn H
Liver Int; 2008 Mar; 28(3):297-307. PubMed ID: 18290772
[TBL] [Abstract][Full Text] [Related]
12. Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.
Cox IJ; Sharif A; Cobbold JF; Thomas HC; Taylor-Robinson SD
World J Gastroenterol; 2006 Aug; 12(30):4773-83. PubMed ID: 16937457
[TBL] [Abstract][Full Text] [Related]
13. Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study.
Mann DV; Lam WW; Magnus Hjelm N; So NM; Yeung DK; Metreweli C; Lau WY
Gut; 2002 Jan; 50(1):118-22. PubMed ID: 11772978
[TBL] [Abstract][Full Text] [Related]
14. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease.
Corbin IR; Buist R; Peeling J; Zhang M; Uhanova J; Minuk GY
Gut; 2003 Jul; 52(7):1046-53. PubMed ID: 12801965
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
[TBL] [Abstract][Full Text] [Related]
16. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.
Cox IJ; Menon DK; Sargentoni J; Bryant DJ; Collins AG; Coutts GA; Iles RA; Bell JD; Benjamin IS; Gilbey S
J Hepatol; 1992 Mar; 14(2-3):265-75. PubMed ID: 1323598
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
[TBL] [Abstract][Full Text] [Related]
18. In vivo 1H magnetic resonance spectroscopy in evaluation of hepatocellular carcinoma and its early response to transcatheter arterial chemoembolization.
Wu B; Peng WJ; Wang PJ; Gu YJ; Li WT; Zhou LP; Tang F; Zhong GM
Chin Med Sci J; 2006 Dec; 21(4):258-64. PubMed ID: 17249202
[TBL] [Abstract][Full Text] [Related]
19. Assessment of mouse liver [1-13C]pyruvate metabolism by dynamic hyperpolarized MRS.
Faarkrog Høyer K; Laustsen C; Ringgaard S; Qi H; Mariager CØ; Nielsen TS; Sundekilde UK; Treebak JT; Jessen N; Stødkilde-Jørgensen H
J Endocrinol; 2019 Sep; 242(3):251-260. PubMed ID: 31311004
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the specific absorption rate and calibration of decoupling parameters for proton decoupled carbon-13 MR spectroscopy at 3.0 T.
Saito M; Matsuda T; Tropp J; Inubushi T; Nakai T
Eur J Radiol; 2005 Aug; 55(2):289-93. PubMed ID: 16036162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
